News from IAS 2011

The 6th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2011) took place in Rome, Italy, 17-20th July, with more than 5000 delegates.

As the official online partner for scientific reporting, NAM published six free email bulletins, with original news reporting and links to abstracts.

The conference included an interesting and diverse collection of presentations and sessions, covering a broad range of subjects in the HIV field, including new treatment, prevention and practice research.

This year’s conference had a major focus on treatment as prevention and on the use of antiretrovirals as pre-exposure prophylaxis (PrEP).

All our news reports from the conference are listed here, for the summary bulletins in English, French, Spanish, Portuguese or Russian, visit our conference bulletin page.

aidsmap news from IAS 2011

Maraviroc improves liver fibrosis in HIV/hepatitis C co-infected patients

Treatment with maraviroc is associated with the regression of liver fibrosis in HIV-positive patients co-infected with hepatitis C, a small randomised study presented to the Sixth International AIDS

Published
20 July 2011
By
Michael Carter
Treatment as prevention: what are the next steps?

Turning treatment into a prevention tool that can end the HIV pandemic will require not one, but a host of different improvements, in the delivery of health

Published
20 July 2011
By
Keith Alcorn
Small study shows women on stable HIV therapy have very low levels of HIV and high drug concentrations in genital fluids

A study of paired samples collected from the blood and cervico-vaginal fluid (CVF) of 20 women on stable antiretroviral therapy has found little evidence that there are

Published
19 July 2011
By
Gus Cairns
Raltegravir combined with Kaletra associated with good preservation of bone density over 96 weeks

A two-drug antiretroviral combination comprising raltegravir and ritonavir-boosted lopinavir has only a modest impact on bone mineral density, a study presented to the International AIDS Society conference (IAS

Published
19 July 2011
By
Michael Carter
South Africa's PMTCT programme reduces mother-to-child transmission to under 4%

Nine years after the start of a national prevention of mother-to-child transmission (PMTCT) programme, South Africa’s mother-to-child HIV  transmission (MTCT) rate is under 4% at four to eight

Published
19 July 2011
By
Carole Leach-Lemens
Daily aciclovir slows HIV disease progression and reduces viral load

Daily treatment with standard-dose aciclovir delays HIV disease progression and lowers viral load in patients co-infected with herpes simplex virus-2 (HSV-2), results of a study presented to the

Published
19 July 2011
By
Michael Carter
Viral suppression reduces HIV risk despite more sex and 'condom fatigue' in patients starting treatment in Cameroon

Concerns that HIV treatment may lead to increased rates of unprotected sex and a decline in condom use need to be considered in the context

Published
19 July 2011
By
Gus Cairns
Testing project using social networks in rural Tanzania effective in identifying people with undiagnosed infection

A pilot project in which people with HIV encouraged their friends and neighbours to be tested for HIV succeeded in recruiting people with a very high rate

Published
19 July 2011
By
Roger Pebody
How best to deploy point-of-care CD4 cell testing in resource-limited settings?

Widespread introduction of point-of-care (POC) CD4 cell tests that don’t require a laboratory technician but can be performed onsite by a nurse, providing results in less than

Published
19 July 2011
By
Theo Smart
Pre-exposure prophylaxis does work for women, two studies find

Two studies of the use of oral pre-exposure prophylaxis (PrEP) in heterosexual people show that oral PrEP will protect women against HIV. The 6th International AIDS Society

Published
19 July 2011
By
Gus Cairns
← Prev1234Next →

Coverage of the conference from CCO

Clinical Care Options (CCO) is the other official online partner of the conference. It will be providing audio highlights, capsule summaries and downloadable slidesets and we will link to their coverage in our news and bulletins, so you can have the fullest picture of the conference.

"Ending the epidemic is scientifically doable"

From 'what if' to 'what now': implementing the new prevention technologies.

Read this news story >

Treatment is prevention

HPTN 052 study shows 96% reduction in transmission when HIV-positive partner starts treatment early.

Read this news story >

Hormonal contraception and HIV

Hormonal contraceptive use increases women’s risk of acquiring and transmitting HIV.

Read this news story >

PrEP works for women too

Pre-exposure prophylaxis does work for women, two studies find.

Read this news story >
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.